NRXP
NRx Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.49
+1.75%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 22.90x
- P/S forward
- 1.78x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -888.84x
- Price / sales
- 44.52x
- Price / cash flow
- -7.64x
Enterprise value
- Enterprise value
- $125.7M
- EV / sales
- 37.02x
- EV / EBITDA
- -5.72x
- EV / EBIT
- -6.29x
- Market cap
- $151.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026